Sun Pharma to test pancreatitis drug in COVID-19 patients in India

Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in COVID-19 patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news